Quantitative Market Risk Assessment: Macy's, Inc.
Interest Rate Sensitivity Exposure
Magnitude of Exposure and Structure
The Company is exposed to interest rate risk stemming from its general borrowing activities and the funding operations associated with its credit card portfolio. While all current borrowings are structured under fixed-rate instruments, this exposure remains inherent in the financing structure. The document notes that the Company may utilize derivative financial instruments when deemed appropriate to manage these movements.
Hedging and Mitigation Strategies
The primary mitigation strategies include:
- Fixed Rate Instruments: All existing borrowings are held under fixed rate agreements.
- Derivatives: The Company employs interest rate swap and interest rate cap agreements "from time to time" to help manage exposure and potentially reduce borrowing costs.
Assessment (Strengths and Weaknesses)
- Strength: The Company maintains a conservative risk profile, explicitly stating it does not use financial instruments for trading or speculative purposes, nor is it involved in leveraged financial instruments. Furthermore, as of February 1, 2025, the Company determined there was "no material market risk exposure" due to its lack of outstanding market risk sensitive instruments on that date.
- Weakness: The reliance on derivative contracts (swaps and caps) indicates an active management requirement. While these tools are used for mitigation, their effectiveness depends entirely on proper execution and ongoing monitoring.
Foreign Currency Exposure
The provided disclosure does not contain any information regarding foreign currency exposure, the currencies involved, or associated translation or transaction risks.
Commodity Price Risk
The provided disclosure does not mention any key commodities, contract structures, or the impact of commodity price fluctuations on margins.
Equity Price Risk
The provided disclosure does not detail the composition of any investment portfolio, nor does it provide information regarding mark-to-market impacts related to equity price changes.
Quantitative Measures and Stress Testing
No quantitative risk measures are disclosed in this filing excerpt. Specifically, there is no mention of Value-at-Risk (VaR) calculations, sensitivity tables, or results from stress testing scenarios.